Filter Results:
(473)
Show Results For
- All HBS Web (473)
- Faculty Publications (105)
Show Results For
- All HBS Web (473)
- Faculty Publications (105)
- October 2009 (Revised August 2014)
- Case
Tengion: Bringing Regenerative Medicine to Life
By: Elie Ofek and Polly Ross Ribatt
Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details
Keywords: Decision Choices and Conditions; Financial Crisis; Entrepreneurship; Health Care and Treatment; Technological Innovation; Product Launch; Product Development; Research and Development; Biotechnology Industry; United States
Ofek, Elie, and Polly Ross Ribatt. "Tengion: Bringing Regenerative Medicine to Life." Harvard Business School Case 510-031, October 2009. (Revised August 2014.)
- 2018
- Working Paper
Zig-Zagging Your Way to Transformative Impact
By: V. Kasturi Rangan and Tricia Gregg
Achieving transformative impact has been much discussed by social entrepreneurs, funders, and consultants. These discussions have focused on issues of increasing impact and scale, but often with no clear distinction between the two terms. In order to provide clarity,... View Details
Keywords: Social Entrepreneurship; Performance Efficiency; Growth and Development; Outcome or Result; Strategy
Rangan, V. Kasturi, and Tricia Gregg. "Zig-Zagging Your Way to Transformative Impact." Harvard Business School Working Paper, No. 18-062, January 2018.
- 26 Mar 2019
- First Look
New Research and Ideas, March 26, 2019
record health worker attendance and patient adherence to protocol, and they automatically prompt follow-up treatment. We combine data from surveys, independent field visits, and government registers to identify impacts on TB-control... View Details
Keywords: Dina Gerdeman
- 30 May 2024
- Research & Ideas
Racial Bias Might Be Infecting Patient Portals. Can AI Help?
convenience and speed. The report’s conclusion invites further study. Explanations for the disparities that the authors document range from differences in the types of questions or requests made by patients in the messages, the syntax of the message and its level of... View Details
- 30 Mar 2010
- First Look
First Look: March 30
outcomes salient (Burns & Corpus, 2004), the bias did not emerge when the presentation did not draw attention to recent outcomes. Fixing Health Care on the Front Lines Author:Richard M.J. Bohmer Publication:Harvard Business Review 88,... View Details
Keywords: Sean Silverthorne
- 2010
- Chapter
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
By: Arthur A. Daemmrich
Adverse drug reactions pose distinct but potentially catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Business and Government Relations; Risk and Uncertainty; Safety; Pharmaceutical Industry; United States
Daemmrich, Arthur A. "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance." Chap. 13 in The Fragmentation of U.S. Health Care: Causes and Solutions, edited by Einer Elhauge, 301–322. Oxford: Oxford University Press, 2010.
- January 2024 (Revised April 2024)
- Case
Target Malaria: Editing Mosquitoes through Gene Drives
By: Shikhar Ghosh and Shweta Bagai
Target Malaria, a non-profit research consortium, is exploring the application of CRISPR-Cas9 gene editing technology to combat malaria in Sub-Saharan Africa. Its approach uses gene drives, a revolutionary tool, to suppress the population of malaria-carrying... View Details
Keywords: Health Disorders; Technological Innovation; Nonprofit Organizations; Business Strategy; Genetics; Ethics; Governing Rules, Regulations, and Reforms; United States; United Kingdom; Burkina Faso; Africa
Ghosh, Shikhar, and Shweta Bagai. "Target Malaria: Editing Mosquitoes through Gene Drives." Harvard Business School Case 824-068, January 2024. (Revised April 2024.)
- Web
Great American Business Leaders of the 20th Century - Leadership
Stephen W. Sanger General Mills, 1995–Present David Sarnoff Radio Corporation of America, 1930–1966 Clarence Saunders Piggly Wiggly Stores, 1916–1924 George A. Schaefer Caterpillar Tractor Company, 1985–1990 Leonard D. Schaeffer Wellpoint View Details
- 11 Feb 2014
- First Look
First Look: February 11
Publications August 2013 American Journal of Managed Care The Impact of Electronic Health Record Use on Physician Productivity By: Adler-Milstein, Julia, and Robert S. Huckman Abstract—Objectives: To examine the impact of the degree of... View Details
Keywords: Sean Silverthorne
- 02 Apr 2013
- First Look
First Look: April 2
Publications 2006 Nature Reviews Beyond Magic Bullets: True Innovation in Health Care By: Narayan, Vaibhav A., Marco Mohwinckel, Gary Pisano, Michael Yang, and Husseini Manji Abstract—The molecular medicine revolution-based on advances... View Details
Keywords: Sean Silverthorne
- Web
Key Concepts - Institute For Strategy And Competitiveness
patients into paying customers, mergers, analytics, big data, personalized or precision medicine, and population health to name a few. None was successful in improving outcomes and controlling cost. On that... View Details
- 21 Dec 2010
- First Look
First Look: December 21
hospital, considers which organizational structure will help them adjust to the changing health sector environment. The move from global budget to activity-based funding has led his and many other public hospitals to suffer losses in... View Details
- 31 Jul 2013
- Working Paper Summaries
Learning from Double-Digit Growth Experiences
Keywords: by Eric D. Werker
- 03 Oct 2023
- Research Event
Build the Life You Want: Arthur Brooks and Oprah Winfrey Share Happiness Tips
when they have very intense negative emotions there's something wrong with them. No, on the contrary, half of the population has unusually intense negative emotions. So one of the things that we do is we use a very famous psychological... View Details
Keywords: by HBS Staff
- 2018
- Chapter
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new... View Details
Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly
Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.
- March 2008 (Revised June 2008)
- Case
The Broad Institute: Applying the Power of Genomics to Medicine
By: Vicki L. Sato and Rachel Gordon
In June 2003, Harvard University and MIT announced an unprecedented partnership to create a biomedical institute, The Broad Institute. The culture of the Broad centered on science, and those involved considered it to be at the edge of the scientific frontier. In just... View Details
Keywords: Education; Health Care and Treatment; Innovation Leadership; Growth and Development Strategy; Organizational Culture; Partners and Partnerships; Research and Development; Genetics
Sato, Vicki L., and Rachel Gordon. "The Broad Institute: Applying the Power of Genomics to Medicine." Harvard Business School Case 608-114, March 2008. (Revised June 2008.)
- Web
Podcast - Business & Environment
Professor Mike Toffel, Faculty Chair, Business & Environment Initiative Guest: Robin Riedel, Partner and co-head of the McKinsey Center for Future Mobility For transcripts and other resources, visit climaterising.org The Health Risks of... View Details
- Article
TDABC Cost Analysis of Ocular Disorders in an Ophthalmology Emergency Department versus Urgent Care: Clinical Experience at Massachusetts Eye and Ear
By: Robert S. Kaplan, Jonathan Chou, Mahek Shah, Amy Watts, Matthew Gardiner, Joan Miller and John I. Lowenstein
Purpose
To perform a cost analysis comparison for managing common ocular disorders in an eye emergency department (ED) versus an urgent care setting using a time-driven activity-based cost model (TDABC) to assist physicians and staff in appropriate allocation of... View Details
Keywords: Time-driven Activity-based Cost Model; Emergency Room; Urgent Care Clinic; Cost; Analysis; Activity Based Costing and Management; Health Care and Treatment
Kaplan, Robert S., Jonathan Chou, Mahek Shah, Amy Watts, Matthew Gardiner, Joan Miller, and John I. Lowenstein. "TDABC Cost Analysis of Ocular Disorders in an Ophthalmology Emergency Department versus Urgent Care: Clinical Experience at Massachusetts Eye and Ear." Journal of Academic Ophthalmology 10 (2018).
- 09 Jan 2014
- Working Paper Summaries
Economic Transition and Private-Sector Labor Demand: Evidence from Urban China
- Web
Latin America - Global
Latin America Mexico City, Montevideo, São Paulo HBS has had a longstanding footprint in Latin America for over 20 years. The Latin America Research Center (LARC) opened in 2000 to satisfy strong interest on the part of the HBS faculty in... View Details